Severe ovarian hyperstimulation syndrome, selective embryo reduction and heterotopic pregnancy.
Ovarian hyperstimulation syndrome is common (21.4%) in patients with polycystic ovarian disease, treated by gonadotrophins. It is much frequent (50%) in conceptual cycles. We report a case associated with a quadruplet pregnancy that underwent selective embryo reduction at 8 weeks' gestation to a twin pregnancy and was subsequently found to have an unruptured ectopic pregnancy at 11 weeks' gestation. After laparotomy and partial salpingectomy a successful twin pregnancy ensued.
Mascarenhas
L
L
Birmingham Maternity Hospital, Edgbaston, UK.
Eliot
B
B
D000032:Abortion, Therapeutic; D000328:Adult; D006063:Chorionic Gonadotropin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000628:therapy; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications*; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000150:complications* / Q000601:surgery; D011272:Pregnancy, Multiple
D006063:Chorionic Gonadotropin